{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:26:11Z","timestamp":1786998371493,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014980","name":"Wannan Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010108","name":"Zhongshan Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010854","name":"Jiangsu Provincial Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014358","name":"Second Affiliated Hospital of Soochow University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019331","name":"Yale Institute for Global Health, Yale School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010012","name":"National Aerospace Science Foundation of China","doi-asserted-by":"publisher","award":["82202932"],"award-info":[{"award-number":["82202932"]}],"id":[{"id":"10.13039\/501100010012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20220735"],"award-info":[{"award-number":["BK20220735"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ygyno.2024.07.688","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T22:46:29Z","timestamp":1724798789000},"page":"167-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["SVIL promotes ovarian cancer progression and epithelial-mesenchymal transition under hypoxic conditions through the TGF-\u03b2\/Smad pathway"],"prefix":"10.1016","volume":"190","author":[{"given":"Dongfang","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congzhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxue","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2024.07.688_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.688_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0950-3552(89)80036-7","article-title":"The spread of ovarian cancer","volume":"3","author":"Pickel","year":"1989","journal-title":"Baillieres Clin. Obstet. Gynaecol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.07.688_bb0015","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.688_bb0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.688_bb0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia\u2013a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2024.07.688_bb0030","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrc.2016.84","article-title":"Oxygen availability and metabolic adaptations","volume":"16","author":"Nakazawa","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2024.07.688_bb0035","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"H\u00f6ckel","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.688_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(03)00012-0","article-title":"Prognostic significance of tumor oxygenation in humans","volume":"195","author":"Evans","year":"2003","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.ygyno.2024.07.688_bb0045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2007.04.019","article-title":"Hypoxia-inducible factors, stem cells, and cancer","volume":"129","author":"Keith","year":"2007","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.ygyno.2024.07.688_bb0050","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.7150\/thno.41792","article-title":"Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer","volume":"10","author":"Lu","year":"2020","journal-title":"Theranostics"},{"issue":"16","key":"10.1016\/j.ygyno.2024.07.688_bb0055","doi-asserted-by":"crossref","first-page":"7983","DOI":"10.1158\/0008-5472.CAN-05-4381","article-title":"Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo","volume":"66","author":"Kim","year":"2006","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.688_bb0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.canlet.2016.01.009","article-title":"Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism","volume":"373","author":"Ai","year":"2016","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.ygyno.2024.07.688_bb0065","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bcp.2007.04.003","article-title":"Cisplatin and doxorubicin repress vascular endothelial growth factor expression and differentially down-regulate hypoxia-inducible factor I activity in human ovarian cancer cells","volume":"74","author":"Duyndam","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ygyno.2024.07.688_bb0070","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/1471-2407-8-335","article-title":"Prognostic significance of hypoxia-inducible factor 1 alpha(HIF-1 alpha) expression in serous ovarian cancer: an immunohistochemical study","volume":"8","author":"Daponte","year":"2008","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.688_bb0075","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1756-9966-29-124","article-title":"The proliferation, apoptosis, invasion of endothelial-like epithelial ovarian cancer cells induced by hypoxia","volume":"29","author":"Zhu","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2024.07.688_bb0080","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1091\/mbc.e08-08-0867","article-title":"Supervillin reorganizes the actin cytoskeleton and increases invadopodial efficiency","volume":"20","author":"Crowley","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ygyno.2024.07.688_bb0085","first-page":"3627","article-title":"The role of PLK1-phosphorylated SVIL in myosin II activation and cytokinetic furrowing","volume":"126","author":"H, H","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ygyno.2024.07.688_bb0090","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.lungcan.2020.07.005","article-title":"Genetic association of gemcitabine\/carboplatin-induced leukopenia and neutropenia in non-small cell lung cancer patients using whole-exome sequencing","volume":"147","author":"Svedberg","year":"2020","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.688_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbrc.2016.11.013","article-title":"A novel splice variant of supervillin, SV5, promotes carcinoma cell proliferation and cell migration","volume":"482","author":"Chen","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.ygyno.2024.07.688_bb0100","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1074\/jbc.M112.416842","article-title":"Supervillin-mediated suppression of p53 protein enhances cell survival","volume":"288","author":"Fang","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.688_bb0105","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-018-0787-2","article-title":"Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA\/ROCK-ERK\/p38 pathway","volume":"37","author":"Chen","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ygyno.2024.07.688_bb0110","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3892\/or.2020.7621","article-title":"Supervillin promotes tumor angiogenesis in liver cancer","volume":"44","author":"C, Z","year":"2020","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.ygyno.2024.07.688_bb0115","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1038\/s41596-018-0075-9","article-title":"Lentiviral transduction of mammalian cells for fast, scalable and high-level production of soluble and membrane proteins","volume":"13","author":"Elegheert","year":"2018","journal-title":"Nat. Protoc."},{"issue":"6","key":"10.1016\/j.ygyno.2024.07.688_bb0120","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/cm.20449","article-title":"Novel interactors and a role for supervillin in early cytokinesis","volume":"67","author":"Smith","year":"2010","journal-title":"Cytoskeleton (Hoboken, N.J.)"},{"issue":"3\u20134","key":"10.1016\/j.ygyno.2024.07.688_bb0125","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10142-021-00789-6","article-title":"Transcriptomic analysis of castration, chemo-resistant and metastatic prostate cancer elucidates complex genetic crosstalk leading to disease progression","volume":"21","author":"Mukherjee","year":"2021","journal-title":"Funct. Integr. Genomics"},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.688_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41759-1","article-title":"Duality of the SVIL expression in bladder cancer and its correlation with immune infiltration","volume":"13","author":"Nie","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ygyno.2024.07.688_bb0135","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/febs.15844","article-title":"The duality of PRDM proteins: epigenetic and structural perspectives","volume":"289","author":"Di Tullio","year":"2022","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.688_bb0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cm.21210","article-title":"Supervillin binds the Rac\/Rho-GEF Trio and increases Trio-mediated Rac1 activation","volume":"72","author":"Son","year":"2015","journal-title":"Cytoskeleton (Hoboken, N.J.)"},{"key":"10.1016\/j.ygyno.2024.07.688_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100715","article-title":"Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance","volume":"53","author":"Erin","year":"2020","journal-title":"Drug Resist. Updat."},{"issue":"6","key":"10.1016\/j.ygyno.2024.07.688_bb0150","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1600-0854.2010.01062.x","article-title":"The membrane-associated protein, supervillin, accelerates F-actin-dependent rapid integrin recycling and cell motility","volume":"11","author":"Fang","year":"2010","journal-title":"Traffic"},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.688_bb0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cytogfr.2004.11.002","article-title":"Dual role for TGF-beta1 in apoptosis","volume":"16","author":"S\u00e1nchez-Capelo","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"issue":"8","key":"10.1016\/j.ygyno.2024.07.688_bb0160","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1073\/pnas.88.8.3412","article-title":"Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells","volume":"88","author":"Rotello","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"14","key":"10.1016\/j.ygyno.2024.07.688_bb0165","first-page":"4042","article-title":"Transforming growth factor beta 1 induces apoptotic cell death in cultured human gastric carcinoma cells","volume":"52","author":"Yanagihara","year":"1992","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.ygyno.2024.07.688_bb0170","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/sj.onc.1202052","article-title":"Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells","volume":"17","author":"Yanagisawa","year":"1998","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.ygyno.2024.07.688_bb0175","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1002\/1521-4141(200012)30:12<3680::AID-IMMU3680>3.0.CO;2-L","article-title":"TGF-beta induces the expression of the FLICE-inhibitory protein and inhibits Fas-mediated apoptosis of microglia","volume":"30","author":"Schlapbach","year":"2000","journal-title":"Eur. J. Immunol."},{"issue":"14","key":"10.1016\/j.ygyno.2024.07.688_bb0180","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1093\/emboj\/cdf366","article-title":"TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses","volume":"21","author":"Yu","year":"2002","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.688_bb0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ygyno.2024.07.688_bb0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.ygyno.2024.07.688_bb0195","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.trecan.2016.10.016","article-title":"Hypoxia-inducible factors: master regulators of cancer progression","volume":"2","author":"Schito","year":"2016","journal-title":"Trends Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2024.07.688_bb0200","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrm3434","article-title":"TGF\u03b2 signalling in context","volume":"13","author":"Massagu\u00e9","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.ygyno.2024.07.688_bb0205","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tips.2015.04.005","article-title":"FDA-approved small-molecule kinase inhibitors","volume":"36","author":"Wu","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"17","key":"10.1016\/j.ygyno.2024.07.688_bb0210","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2174\/1568026620666200516152756","article-title":"Small molecule CDK inhibitors for the therapeutic management of cancer","volume":"20","author":"Goel","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ygyno.2024.07.688_bb0215","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.phrs.2018.11.014","article-title":"Small molecule inhibitors targeting the EGFR\/ErbB family of protein-tyrosine kinases in human cancers","volume":"139","author":"Roskoski","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ygyno.2024.07.688_bb0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cytogfr.2019.10.005","article-title":"Novel activators and small-molecule inhibitors of STAT3 in cancer","volume":"49","author":"Yang","year":"2019","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824010515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824010515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T21:05:47Z","timestamp":1730927147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824010515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":44,"alternative-id":["S0090825824010515"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.07.688","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SVIL promotes ovarian cancer progression and epithelial-mesenchymal transition under hypoxic conditions through the TGF-\u03b2\/Smad pathway","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.07.688","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}